Your browser doesn't support javascript.
loading
Monitoring tumour resistance to the BRAF inhibitor combination regimen in colorectal cancer patients via circulating tumour DNA.
Ye, Liu-Fang; Huang, Zi-Yao; Chen, Xiao-Xi; Chen, Zhi-Gang; Wu, Si-Xian; Ren, Chao; Hu, Ming-Tao; Bao, Hua; Jin, Ying; Wang, Feng; Wang, Feng-Hua; Du, Zi-Ming; Wu, Xue; Ju, Huai-Qiang; Shao, Yang; Li, Yu-Hong; Xu, Rui-Hua; Wang, De-Shen.
Affiliation
  • Ye LF; Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University, Guangzhou 510060, P. R. China; Research Unit of Precision Diagnosis and Treatment for Gastrointestinal C
  • Huang ZY; Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University, Guangzhou 510060, P. R. China; Research Unit of Precision Diagnosis and Treatment for Gastrointestinal C
  • Chen XX; Geneseeq Research Institute, Nanjing Geneseeq Technology Inc., Nanjing, Jiangsu, P. R. China.
  • Chen ZG; Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University, Guangzhou 510060, P. R. China; Research Unit of Precision Diagnosis and Treatment for Gastrointestinal C
  • Wu SX; Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University, Guangzhou 510060, P. R. China; Research Unit of Precision Diagnosis and Treatment for Gastrointestinal C
  • Ren C; Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University, Guangzhou 510060, P. R. China; Research Unit of Precision Diagnosis and Treatment for Gastrointestinal C
  • Hu MT; Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University, Guangzhou 510060, P. R. China; Research Unit of Precision Diagnosis and Treatment for Gastrointestinal C
  • Bao H; Geneseeq Research Institute, Nanjing Geneseeq Technology Inc., Nanjing, Jiangsu, P. R. China.
  • Jin Y; Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University, Guangzhou 510060, P. R. China; Research Unit of Precision Diagnosis and Treatment for Gastrointestinal C
  • Wang F; Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University, Guangzhou 510060, P. R. China; Research Unit of Precision Diagnosis and Treatment for Gastrointestinal C
  • Wang FH; Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University, Guangzhou 510060, P. R. China; Research Unit of Precision Diagnosis and Treatment for Gastrointestinal C
  • Du ZM; Department of Molecular Diagnostics, Sun Yat-sen University Cancer Center, Guangzhou 510060, P. R. China.
  • Wu X; Geneseeq Research Institute, Nanjing Geneseeq Technology Inc., Nanjing, Jiangsu, P. R. China.
  • Ju HQ; Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University, Guangzhou 510060, P. R. China; Research Unit of Precision Diagnosis and Treatment for Gastrointestinal C
  • Shao Y; Geneseeq Research Institute, Nanjing Geneseeq Technology Inc., Nanjing, Jiangsu, P. R. China; School of Public Health, Nanjing Medical University, Nanjing, P. R. China.
  • Li YH; Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University, Guangzhou 510060, P. R. China; Research Unit of Precision Diagnosis and Treatment for Gastrointestinal C
  • Xu RH; Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University, Guangzhou 510060, P. R. China; Research Unit of Precision Diagnosis and Treatment for Gastrointestinal C
  • Wang DS; Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University, Guangzhou 510060, P. R. China; Research Unit of Precision Diagnosis and Treatment for Gastrointestinal C
Drug Resist Updat ; 65: 100883, 2022 12.
Article in En | MEDLINE | ID: mdl-36202008
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Drug Resistance, Neoplasm / Circulating Tumor DNA Type of study: Guideline / Observational_studies / Prognostic_studies Limits: Humans Language: En Journal: Drug Resist Updat Year: 2022 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Drug Resistance, Neoplasm / Circulating Tumor DNA Type of study: Guideline / Observational_studies / Prognostic_studies Limits: Humans Language: En Journal: Drug Resist Updat Year: 2022 Document type: Article